| 1 |
24508126 | Vascular endothelial growth factor c promotes ovarian carcinoma progression through paracrine and autocrine mechanisms. | 2014 Apr |
1 |
| 2 |
24714778 | Phase II study of cediranib in patients with advanced gastrointestinal stromal tumors or soft-tissue sarcoma. | 2014 Jul 1 |
1 |
| 3 |
19674789 | An open-label, Phase I study of cediranib (RECENTIN) in patients with acute myeloid leukemia. | 2010 Feb |
1 |
| 4 |
19826113 | Cediranib, an oral inhibitor of vascular endothelial growth factor receptor kinases, is an active drug in recurrent epithelial ovarian, fallopian tube, and peritoneal cancer. | 2009 Nov 20 |
1 |
| 5 |
18520296 | The tyrosine kinase inhibitor cediranib for non-small cell lung cancer and other thoracic malignancies. | 2008 Jun |
1 |